Arecor Therapeutics plc

("Arecor" or the "Group")

ARECOR TO PRESENT SHARESOC WEBINAR

Cambridge, UK, 1 March 2023: Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical group advancing today's therapies to enable healthier lives, today announces that Sarah Howell, Chief Executive Officer and Susan Lowther, Chief Financial Officer will be presenting a live ShareSoc webinar on Tuesday 7 March at 4:00pm GMT.

The presentation is open to all existing and potential shareholders and will provide a full overview of the company with an update on current performance and progress of its proprietary portfolio and partnered programmes. The presentation will be followed by a Q&A session. No new information will be disclosed during the event.

Further details of the event, along with a registration form, are available here: https://www.sharesoc.org/events/sharesoc-webinar-with-arecor-therapeutics-plc-arec07-march-2023/

-ENDS-

For more information, please contact:

Notes to Editors

About Arecor

Arecor Therapeutics plc is a globally focused biopharmaceutical company transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying our innovative proprietary formulation technology platform, Arestat™, we are developing an internal portfolio of proprietary products in diabetes and other indications, as well as working with leading pharmaceutical and biotechnology companies to deliver enhanced formulations of their therapeutic products. The Arestat™ platform is supported by an extensive patent portfolio. 

For further details please see our website, www.arecor.com